×
About 160 results

ALLMedicine™ Factor V Deficiency Center

Research & Reviews  62 results

Primary Myelofibrosis Clinical Presentation
https://emedicine.medscape.com/article/197954-clinical

Mar 3rd, 2022 - History One fourth of patients with primary myelofibrosis are asymptomatic, and the diagnosis is made as a result of detecting splenomegaly or checking blood cell counts for an unrelated cause. Symptoms may occur as a result of anemia, splenomegal...

A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a...
https://doi.org/10.1055/s-0041-1740149
Seminars in Thrombosis and Hemostasis; Ichinose A, Osaki T et. al.

Dec 24th, 2021 - Coagulation factor V (or FV for the purpose of medical safety) is an essential cofactor of coagulation factor X in the common pathway of coagulation; severe FV deficiency leads to a bleeding tendency. Although both congenital and acquired FV defic...

Clinical Phenotype and Genetic Analysis of Twins With Congenital Coagulation Factor V D...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876379
Journal of Pediatric Hematology/oncology; Wei Y, He Y et. al.

Aug 14th, 2021 - The aim was to investigate the clinical characteristics and molecular pathogenic mechanism of twins with congenital factor V (FV) deficiency. We comprehensively analyzed the clinical manifestations and laboratory test results of a set of twins and...

Factor V Assay
http://emedicine.medscape.com/article/2085248-overview

Aug 3rd, 2021 - Reference Range Factor V is a large glycoprotein with a molecular weight of 330,000 daltons and a plasma half-life of about 12 hours, with some reports of a half-life of up to 36 hours. [1] It functions as a cofactor in converting factor II to act...

Factor V Assay
https://emedicine.medscape.com/article/2085248-print

Aug 3rd, 2021 - Factor V is a large glycoprotein with a molecular weight of 330,000 daltons and a plasma half-life of about 12 hours, with some reports of a half-life of up to 36 hours.[1] It functions as a cofactor in converting factor II to active factor II. It...

see more →

Clinicaltrials.gov  1 results

Prediction of Outcome in Severe Preeclampsia
https://clinicaltrials.gov/ct2/show/NCT03871764

Mar 12th, 2019 - leiden mutation is activated protein C resistance with hypercoagulable states and increased thrombotic risk. 99 % are heterozygous and 1 % is homozygous , very rare cases are psoudohomozygous with factor V deficiency. relation to this mutation was...

see more →

News  1 results

Peering into My Own Genome
https://www.medpagetoday.com/genetics/genetictesting/53088

Aug 16th, 2015 - I have looked into my genome and seen ... nothing much to worry about. I carry 15 rare genetic variants that have been associated with some form of disease, but I am heterozygous for all of them -- I have one intact copy of the same gene. So I car...

see more →